|
Better
to best
The newly launched once-daily dispersible oral iron chelator
is billed to provide much needed relief to thalassaemia patients.
But patients still need to monitor kidney functions, among
other parameters. Suja Nair finds out details
Development
of HIV Vaccine
A review of the possible role of nanoparticles in the development
of HIV vaccines
ACCORD
Study Group presents unexpected findings
Results of the Action to Control Cardiovascular Risk in Diabetes
(ACCORD) Study Group were released at the recent American
Diabetes Association's 68th Scientific Sessions.
Intensive
glucose control reduces serious complications
New results from the world's largest ever study of diabetes
treatments show that intensive blood glucose (sugar) control
using modified release gliclazide and other drugs as required,
protects patients against serious complications of the disease.
|
